AC8 0.00% 4.0¢ auscann group holdings ltd

Ann: AusCann Releases Hard-shell Capsules to Clinical Evaluation, page-25

  1. 44,861 Posts.
    lightbulb Created with Sketch. 642
    this is not a research trial... it IS clinical evaluation... its a pre-market exercise. don't you get this yet?
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.